Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multiple sclerosis: Fatigue-a warning sign for multiple sclerosis?
Estrogen treatment of experimental autoimmune encephalomyelitis requires E2 receptor positive B cells that upregulate PD-1 on CD4(+) Foxp3(+) Treg cells.
Case report of transverse myelitis in a patient receiving etanercept for rheumatoid arthritis.
Combining Double Fluorescence In Situ Hybridization with Immunolabelling for Detection of the Expression of Three Genes in Mouse Brain Sections.
Influence of multiple sclerosis, age and degree of disability, in the position of the contrast sensitivity curve peak.
More on JC viremia in natalizumab-treated patients with multiple sclerosis.
Erythrocytes' antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation.
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity.
Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients.
Examining vascular remodeling in the hypoxic central nervous system.
Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.
PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation.
Modulation of C-nociceptive Activities by Inputs from Myelinated Fibers.
MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.
Duality of Antidepressants and Neuroprotectants.
Beclin 1 regulates neuronal transforming growth factor-β signaling by mediating recycling of the type I receptor ALK5.
Gliopathy of Demyelinating and Non-Demyelinating Strains of Mouse Hepatitis Virus.
Using mental visual imagery to improve autobiographical memory and episodic future thinking in relapsing-remitting multiple sclerosis patients: A randomised-controlled trial study.
Impaired growth of the cerebellum in pediatric-onset acquired CNS demyelinating disease.
Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing.
A Novel MPZ Gene Mutation in Exon 2 Causing Late-Onset Demyelinating Charcot-Marie-Tooth Disease.
Sperm-associated antigen 16 is a novel target of the humoral autoimmune response in multiple sclerosis.
Aquaporin-1 Antibody in Neuromyelitis Optica Patients.
Targeting and liposomal drug delivery to CD40L expressing T cells for treatment of autoimmune diseases.
The Role of fMRI to Assess Plasticity of the Motor System in MS.
Pages
« first
‹ previous
…
625
626
627
628
629
630
631
632
633
…
next ›
last »